[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:acute-b-lymphoblastic-leukemia":3},{"name":4,"total":5,"trials":6,"biomarkers":14,"states":15},"Acute B-Lymphoblastic Leukemia",1,[7],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT07717164","The Rationale to Conduct This RWE Study is to Provide Data to Support the Safety of CD34 Selected Grafts Versus T Replete PBSC Transplants to Address Concerns About Increased TRM in CD34 Selected Graft Recipients.",[],"NOT_YET_RECRUITING","2026-08-03T01:02:42.162342Z","2026-07-24T01:27:14.916627Z",[],[]]